01 1AURORE PHARMACEUTICALS PRIVATE LIMITED
01 1NAFAMOSTAT MESYLATE JP
01 1India
NDC Package Code : 72761-028
Start Marketing Date : 2020-07-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
72
PharmaCompass offers a list of Nafamostat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nafamostat manufacturer or Nafamostat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nafamostat manufacturer or Nafamostat supplier.
PharmaCompass also assists you with knowing the Nafamostat API Price utilized in the formulation of products. Nafamostat API Price is not always fixed or binding as the Nafamostat Price is obtained through a variety of data sources. The Nafamostat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Nafamostat Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nafamostat Mesylate, including repackagers and relabelers. The FDA regulates Nafamostat Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nafamostat Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nafamostat Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nafamostat Mesylate supplier is an individual or a company that provides Nafamostat Mesylate active pharmaceutical ingredient (API) or Nafamostat Mesylate finished formulations upon request. The Nafamostat Mesylate suppliers may include Nafamostat Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Nafamostat Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Nafamostat Mesylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Nafamostat Mesylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Nafamostat Mesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Nafamostat Mesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Nafamostat Mesylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Nafamostat Mesylate suppliers with NDC on PharmaCompass.
We have 1 companies offering Nafamostat Mesylate
Get in contact with the supplier of your choice:
